Compass Therapeutics Statistics

Total Valuation

CMPX has a market cap or net worth of $128.89 million. The enterprise value is -$25.95 million.

Market Cap	128.89M
Enterprise Value	-25.95M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

CMPX has 137.59 million shares outstanding. The number of shares has increased by 8.10% in one year.

Shares Outstanding	137.59M
Shares Change (YoY)	+8.10%
Shares Change (QoQ)	+7.06%
Owned by Insiders (%)	12.04%
Owned by Institutions (%)	70.84%
Float	98.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.82
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 40.74, with a Debt / Equity ratio of 0.01.

Current Ratio	40.74
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.70% and return on invested capital (ROIC) is -33.71%.

Return on Equity (ROE)	-28.70%
Return on Assets (ROA)	-27.20%
Return on Capital (ROIC)	-33.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.42M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.04% in the last 52 weeks. The beta is 0.62, so CMPX's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-65.04%
50-Day Moving Average	1.24
200-Day Moving Average	1.59
Relative Strength Index (RSI)	40.56
Average Volume (20 Days)	422,577

Short Selling Information

The latest short interest is 1.82 million, so 1.32% of the outstanding shares have been sold short.

Short Interest	1.82M
Short Previous Month	1.58M
Short % of Shares Out	1.32%
Short % of Float	1.85%
Short Ratio (days to cover)	4.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.43M
Pretax Income	-45.44M
Net Income	-45.44M
EBITDA	-43.57M
EBIT	-45.44M
Earnings Per Share (EPS)	-$0.35

Full Income Statement

Balance Sheet

The company has $156.26 million in cash and $1.41 million in debt, giving a net cash position of $154.84 million or $1.13 per share.

Cash & Cash Equivalents	156.26M
Total Debt	1.41M
Net Cash	154.84M
Net Cash Per Share	$1.13
Equity (Book Value)	157.06M
Book Value Per Share	1.14
Working Capital	154.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.28 million and capital expenditures -$30,000, giving a free cash flow of -$42.31 million.

Operating Cash Flow	-42.28M
Capital Expenditures	-30,000
Free Cash Flow	-42.31M
FCF Per Share	-$0.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.10%
Shareholder Yield	-8.10%
Earnings Yield	-35.26%
FCF Yield	-32.82%

Analyst Forecast

The average price target for CMPX is $10.00, which is 967.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	967.46%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3